Article 1 to 1 out of 1 concerning Vakzine Projekt Management GmbH (VPM)
Cooperation on the Development of a Malaria Vaccine(23 Dec 2005) The malaria vaccine GMZ2 to be tested in a Phase I clinical trial in Tübingen Vakzine Projekt Management GmbH (VPM) and the European Malaria Vaccine Initiative (EMVI) are cooperating in compiling and submitting the Phase I clinical trial application of malaria vaccine GMZ2 to the Paul-Ehrlich-Institute and to the Ethics ...